Nevada Man Indicted for Smuggling and Selling Misbranded Erectile Dysfunction and Prescription Drugs

LAS VEGAS - A Henderson, Nev., resident made his initial appearance in court on Friday in connection to a 17-count superseding indictment charging him for allegedly smuggling misbranded prescription drugs under the brand names "Ride," "Kinky Kong," "Stif," "TBone," and "Kinky Pink."

According to allegations in the superseding indictment, David Ralph Webber owned and operated Passion Plus Enterprises Inc. and Whole Science Health. He was not a registered pharmaceutical manufacturer with the U.S Food and Drug Administration (FDA), nor was he licensed to administer prescription drugs or as a wholesaler of prescription drugs.

As alleged, from at least 2018 to present, Webber used his companies to import hundreds of thousands of misbranded prescription drug capsules and tablets containing sildenafil, sildenafil citrate, and tadalafil - the active ingredients in Viagra and Cialis - into the United States. The prescription drugs were manufactured in India at facilities that were not registered with the FDA. To evade customs detection and enforcement, Webber falsely declared that the wire transfers to the manufacturers were for business management consultancy services; and he allegedly paid a packaging company to list false ingredients and false claims that the drugs were "100% Natural" and did not require a prescription.

Webber allegedly sold the misbranded prescription drugs to smoke shops, convenience stores, and adult novelty stores in Nevada and throughout the southwestern United States, and directly to consumers through a website he operated. In total, he made more than $1.9 million dollars in revenue from his sales of misbranded prescription drugs.

A federal grand jury returned the superseding indictment charging Webber with one count of introduction of a misbranded drug into interstate commerce; four counts of wholesale distribution of prescription drugs without a license; seven counts of smuggling; and five counts of mail fraud.

A jury trial is set for September 29, 2026, before United States District Judge Jennifer A. Dorsey. The maximum statutory penalty is 20 years in custody.

First Assistant United States Attorney Sigal Chattah for the District of Nevada, Special Agent in Charge Robert M. Iwanicki of the FDA's Office of Criminal Investigations Los Angeles Field Office, and Inspector in Charge Glen Henderson for the United States Postal Inspection Service (USPIS), Phoenix Division made the announcement.

This case was investigated by the FDA and USPIS. Assistant United States Attorneys Jessica Oliva and Kimberly Frayn are prosecuting the case.

If you or someone you know has taken these products and/or suffered adverse health effects as a result of these products, please contact investigators at https://www.accessdata.fda.gov/scripts/email/oc/oci/contact.cfmLinks to other government and non-government sites will typically appear with the "external link" icon to indicate that you are leaving the Department of Justice website when you click the link..

A Superseding Indictment is merely an accusation, and a defendant is presumed innocent unless and until proven guilty.

###